{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T02:42:17Z","timestamp":1793932937898,"version":"4.8.0"},"reference-count":212,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,21]],"date-time":"2025-12-21T00:00:00Z","timestamp":1766275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"vor","delay-in-days":8,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nutr Metab (Lond)"],"DOI":"10.1186\/s12986-025-01068-y","type":"journal-article","created":{"date-parts":[[2025,12,21]],"date-time":"2025-12-21T15:33:55Z","timestamp":1766331235000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["The role of dietary factors in the prevention and management of inflammatory bowel disease: a comprehensive review"],"prefix":"10.1186","volume":"22","author":[{"given":"Elyas","family":"Nattagh-Eshtivani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanieh","family":"Barghchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir Hossein","family":"Mansouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pegah","family":"Rahbarinejad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amin","family":"Mokari-Yamchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Barati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Rashidmyvan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Jafazadeh","family":"Esfehani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Mohammadzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachry","family":"Clyton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parisa","family":"Marabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeedeh","family":"Talebi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naseh","family":"Pahlavani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,21]]},"reference":[{"issue":"9573","key":"1068_CR1","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1016\/S0140-6736(07)60750-8","volume":"369","author":"DC Baumgart","year":"2007","unstructured":"Baumgart DC, Carding SR. Inflammatory bowel disease: cause and immunobiology. Lancet. 2007;369(9573):1627\u201340.","journal-title":"Lancet"},{"issue":"27","key":"1068_CR2","doi-asserted-by":"publisher","first-page":"2652","DOI":"10.1056\/NEJMra2002697","volume":"383","author":"JT Chang","year":"2020","unstructured":"Chang JT. Pathophysiology of inflammatory bowel diseases. N Engl J Med. 2020;383(27):2652\u201364.","journal-title":"N Engl J Med"},{"issue":"2","key":"1068_CR3","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1053\/j.gastro.2016.10.020","volume":"152","author":"GG Kaplan","year":"2017","unstructured":"Kaplan GG, Ng SC. Understanding and preventing the global increase of inflammatory bowel disease. Gastroenterology. 2017;152(2):313\u201321. e2.","journal-title":"Gastroenterology"},{"key":"1068_CR4","doi-asserted-by":"crossref","unstructured":"Lucendo AJ, De Rezende LC. Importance of nutrition in inflammatory bowel disease. World journal of gastroenterology: WJG, 2009. 15(17): p. 2081.","DOI":"10.3748\/wjg.15.2081"},{"issue":"5","key":"1068_CR5","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1136\/gut.2010.224154","volume":"60","author":"C Mowat","year":"2011","unstructured":"Mowat C, et al. Guidelines for the management of inflammatory bowel disease in adults. Gut. 2011;60(5):571\u2013607.","journal-title":"Gut"},{"issue":"1","key":"1068_CR6","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1001\/jama.2020.18936","volume":"325","author":"K Cushing","year":"2021","unstructured":"Cushing K, Higgins PD. Management of Crohn disease: a review. JAMA. 2021;325(1):69\u201380.","journal-title":"JAMA"},{"key":"1068_CR7","doi-asserted-by":"publisher","first-page":"765474","DOI":"10.3389\/fmed.2021.765474","volume":"8","author":"Z Cai","year":"2021","unstructured":"Cai Z, Wang S, Li J. Treatment of inflammatory bowel disease: a comprehensive review. Front Med. 2021;8:765474.","journal-title":"Front Med"},{"issue":"2","key":"1068_CR8","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1002\/ibd.21360","volume":"17","author":"RJ Hilsden","year":"2011","unstructured":"Hilsden RJ, et al. Use of complementary and alternative medicine by patients with inflammatory bowel disease. Inflamm Bowel Dis. 2011;17(2):655\u201362.","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"1068_CR9","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/1751-2980.12686","volume":"20","author":"YQ Zhou","year":"2019","unstructured":"Zhou YQ, Xu RY, Wan YP. The role of dietary factors in inflammatory bowel diseases: new perspectives. J Dig Dis. 2019;20(1):11\u20137.","journal-title":"J Dig Dis"},{"issue":"3","key":"1068_CR10","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.bpg.2006.03.001","volume":"20","author":"M O\u2019Sullivan","year":"2006","unstructured":"O\u2019Sullivan M, O\u2019Morain C. Nutrition in inflammatory bowel disease. Best Pract Res Clin Gastroenterol. 2006;20(3):561\u201373.","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"8","key":"1068_CR11","first-page":"511","volume":"11","author":"K Knight-Sepulveda","year":"2015","unstructured":"Knight-Sepulveda K, et al. Diet and inflammatory bowel disease. Gastroenterol Hepatol. 2015;11(8):511.","journal-title":"Gastroenterol Hepatol"},{"issue":"6","key":"1068_CR12","doi-asserted-by":"publisher","first-page":"674","DOI":"10.3181\/0711-MR-311","volume":"233","author":"AP Simopoulos","year":"2008","unstructured":"Simopoulos AP. The importance of the omega-6\/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases. Experimental Biology Med. 2008;233(6):674\u201388.","journal-title":"Experimental Biology Med"},{"key":"1068_CR13","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1007\/s00394-020-02413-y","volume":"60","author":"SM Ajabnoor","year":"2021","unstructured":"Ajabnoor SM, et al. Long-term effects of increasing omega-3, omega-6 and total polyunsaturated fats on inflammatory bowel disease and markers of inflammation: a systematic review and meta-analysis of randomized controlled trials. Eur J Nutr. 2021;60:2293\u2013316.","journal-title":"Eur J Nutr"},{"issue":"1","key":"1068_CR14","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1097\/MIB.0000000000000585","volume":"22","author":"JK Limdi","year":"2016","unstructured":"Limdi JK, Aggarwal D, McLaughlin JT. Dietary practices and beliefs in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2016;22(1):164\u201370.","journal-title":"Inflamm Bowel Dis"},{"issue":"4","key":"1068_CR15","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.immuni.2009.08.020","volume":"31","author":"V Gaboriau-Routhiau","year":"2009","unstructured":"Gaboriau-Routhiau V, et al. The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses. Immunity. 2009;31(4):677\u201389.","journal-title":"Immunity"},{"issue":"6","key":"1068_CR16","doi-asserted-by":"publisher","first-page":"6ra14","DOI":"10.1126\/scitranslmed.3000322","volume":"1","author":"PJ Turnbaugh","year":"2009","unstructured":"Turnbaugh PJ, et al. The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice. Sci Transl Med. 2009;1(6):6ra14.","journal-title":"Sci Transl Med"},{"issue":"1","key":"1068_CR17","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1136\/gutjnl-2012-304119","volume":"63","author":"M Martinez-Medina","year":"2014","unstructured":"Martinez-Medina M, et al. Western diet induces dysbiosis with increased E coli in CEABAC10 mice, alters host barrier function favouring AIEC colonisation. Gut. 2014;63(1):116\u201324.","journal-title":"Gut"},{"issue":"5","key":"1068_CR18","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1089\/thy.2007.0018","volume":"17","author":"WS Dhillo","year":"2007","unstructured":"Dhillo WS. Appetite regulation: an overview. Thyroid. 2007;17(5):433\u201345.","journal-title":"Thyroid"},{"issue":"3","key":"1068_CR19","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1017\/S0029665116002846","volume":"76","author":"CEL Evans","year":"2017","unstructured":"Evans CEL. Sugars and health: a review of current evidence and future policy. Proc Nutr Soc. 2017;76(3):400\u20137.","journal-title":"Proc Nutr Soc"},{"issue":"1","key":"1068_CR20","doi-asserted-by":"publisher","first-page":"12294","DOI":"10.1038\/s41598-019-48749-2","volume":"9","author":"M Laffin","year":"2019","unstructured":"Laffin M, et al. A high-sugar diet rapidly enhances susceptibility to colitis via depletion of luminal short-chain fatty acids in mice. Sci Rep. 2019;9(1):12294.","journal-title":"Sci Rep"},{"issue":"1","key":"1068_CR21","first-page":"47","volume":"7","author":"A Tragnone","year":"1995","unstructured":"Tragnone A, Valpiani D, Miglio F, Elmi G, Bazzocchi G, Pipitone E, Lanfranchi GA. Dietary habits as risk factors for inflammatory bowel disease. Eur J Gastroenterol Hepatol. 1995;7(1):47\u201351.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"2","key":"1068_CR22","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/00004836-199409000-00019","volume":"19","author":"Dietary and other risk factors of ulcerative colitis","year":"1994","unstructured":"Dietary and other risk factors of ulcerative colitis. A case-control study in Japan. Epidemiology group of the research committee of inflammatory bowel disease in Japan. J Clin Gastroenterol. 1994;19(2):166\u201371.","journal-title":"J Clin Gastroenterol"},{"issue":"1","key":"1068_CR23","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1097\/00001648-199201000-00009","volume":"3","author":"P-G Persson","year":"1992","unstructured":"Persson P-G, Ahlbom A, Hellers G. Diet and inflammatory bowel disease: a case-control study. Epidemiology. 1992;3(1):47\u201352.","journal-title":"Epidemiology"},{"issue":"6","key":"1068_CR24","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1136\/gut.40.6.754","volume":"40","author":"S Reif","year":"1997","unstructured":"Reif S, et al. Pre-illness dietary factors in inflammatory bowel disease. Gut. 1997;40(6):754\u201360.","journal-title":"Gut"},{"issue":"11","key":"1068_CR25","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1097\/MIB.0000000000000168","volume":"20","author":"SS Chan","year":"2014","unstructured":"Chan SS, et al. Carbohydrate intake in the etiology of crohn\u2019s disease and ulcerative colitis. Inflamm Bowel Dis. 2014;20(11):2013\u201321.","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"1068_CR26","first-page":"5","volume":"111","author":"ZQ Jin","year":"2019","unstructured":"Jin ZQ, et al. A meta-analysis of dietary carbohydrate intake and inflammatory bowel disease risk: evidence from 15 epidemiology studies. Rev Esp Enferm Dig. 2019;111(1):5\u20139.","journal-title":"Rev Esp Enferm Dig"},{"issue":"5","key":"1068_CR27","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1016\/j.clnu.2016.10.009","volume":"36","author":"F Wang","year":"2017","unstructured":"Wang F, et al. Carbohydrate and protein intake and risk of ulcerative colitis: systematic review and dose-response meta-analysis of epidemiological studies. Clin Nutr. 2017;36(5):1259\u201365.","journal-title":"Clin Nutr"},{"issue":"10","key":"1068_CR28","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.1016\/j.cgh.2022.11.026","volume":"21","author":"BN Limketkai","year":"2023","unstructured":"Limketkai BN, et al. Dietary interventions for the treatment of inflammatory bowel diseases: an updated systematic review and Meta-analysis. Clin Gastroenterol Hepatol. 2023;21(10):2508\u2013e252510.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1068_CR29","doi-asserted-by":"crossref","unstructured":"Yusuf K, Saha S, Umar S. Health benefits of dietary fiber for the management of inflammatory bowel disease. Biomedicines, 2022. 10(6).","DOI":"10.3390\/biomedicines10061242"},{"issue":"5","key":"1068_CR30","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1093\/nutrit\/nuz072","volume":"78","author":"OG Swann","year":"2020","unstructured":"Swann OG, et al. Dietary fiber and its associations with depression and inflammation. Nutr Rev. 2020;78(5):394\u2013411.","journal-title":"Nutr Rev"},{"issue":"7","key":"1068_CR31","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1136\/gut.2010.232025","volume":"60","author":"JL Benjamin","year":"2011","unstructured":"Benjamin JL, et al. Randomised, double-blind, placebo-controlled trial of fructo-oligosaccharides in active crohn\u2019s disease. Gut. 2011;60(7):923\u20139.","journal-title":"Gut"},{"issue":"1","key":"1068_CR32","first-page":"116","volume":"4","author":"Z Faghfoori","year":"2014","unstructured":"Faghfoori Z, et al. Effects of an oral supplementation of germinated barley foodstuff on serum CRP level and clinical signs in patients with ulcerative colitis. Health Promot Perspect. 2014;4(1):116\u201321.","journal-title":"Health Promot Perspect"},{"issue":"6","key":"1068_CR33","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.chom.2018.05.012","volume":"23","author":"K Makki","year":"2018","unstructured":"Makki K, et al. The impact of dietary fiber on gut microbiota in host health and disease. Cell Host Microbe. 2018;23(6):705\u201315.","journal-title":"Cell Host Microbe"},{"issue":"1","key":"1068_CR34","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jfda.2016.09.006","volume":"25","author":"FJ Dai","year":"2017","unstructured":"Dai FJ, Chau CF. Classification and regulatory perspectives of dietary fiber. J Food Drug Anal. 2017;25(1):37\u201342.","journal-title":"J Food Drug Anal"},{"key":"1068_CR35","doi-asserted-by":"crossref","unstructured":"Cui SW, Nie S, Roberts KT. Functional Properties of Dietary Fiber, in Comprehensive Biotechnology. 2011. pp. 517\u2013525.","DOI":"10.1016\/B978-0-08-088504-9.00315-9"},{"issue":"5","key":"1068_CR36","doi-asserted-by":"publisher","first-page":"388","DOI":"10.2174\/0929866524666170220113312","volume":"24","author":"M Han","year":"2017","unstructured":"Han M, et al. Dietary fiber gap and host gut microbiota. Protein Pept Lett. 2017;24(5):388\u201396.","journal-title":"Protein Pept Lett"},{"issue":"6","key":"1068_CR37","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/j.cgh.2020.05.026","volume":"19","author":"J Fritsch","year":"2021","unstructured":"Fritsch J, et al. Low-Fat, High-Fiber diet reduces markers of inflammation and dysbiosis and improves quality of life in patients with ulcerative colitis. Clin Gastroenterol Hepatol. 2021;19(6):1189\u2013e119930.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1068_CR38","doi-asserted-by":"crossref","unstructured":"Loy L et al. Dietary fiber in inflammatory bowel disease: are we ready to change the paradigm? Nutrients, 2024. 16(8).","DOI":"10.3390\/nu16081108"},{"issue":"2","key":"1068_CR39","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1097\/MOG.0000000000000905","volume":"39","author":"T Yamamoto","year":"2023","unstructured":"Yamamoto T, Shimoyama T. Nutrition and diet in inflammatory bowel disease. Curr Opin Gastroenterol. 2023;39(2):110\u20134.","journal-title":"Curr Opin Gastroenterol"},{"issue":"4","key":"1068_CR40","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1097\/MPG.0000000000001736","volume":"66","author":"A Pituch-Zdanowska","year":"2018","unstructured":"Pituch-Zdanowska A, et al. Dietary fiber intake in children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2018;66(4):624\u20139.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"4","key":"1068_CR41","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.jand.2020.12.001","volume":"121","author":"AS Day","year":"2021","unstructured":"Day AS, et al. The adequacy of habitual dietary fiber intake in individuals with inflammatory bowel disease: A systematic review. J Acad Nutr Diet. 2021;121(4):688\u2013e7083.","journal-title":"J Acad Nutr Diet"},{"issue":"1","key":"1068_CR42","doi-asserted-by":"publisher","first-page":"58","DOI":"10.7812\/TPP\/14-124","volume":"19","author":"M Chiba","year":"2015","unstructured":"Chiba M, et al. High amount of dietary fiber not harmful but favorable for Crohn disease. Perm J. 2015;19(1):58\u201361.","journal-title":"Perm J"},{"issue":"3","key":"1068_CR43","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1093\/advances\/nmaa145","volume":"12","author":"A Milajerdi","year":"2021","unstructured":"Milajerdi A, et al. Association of dietary Fiber, Fruit, and vegetable consumption with risk of inflammatory bowel disease: A systematic review and Meta-Analysis. Adv Nutr. 2021;12(3):735\u201343.","journal-title":"Adv Nutr"},{"key":"1068_CR44","doi-asserted-by":"publisher","first-page":"658354","DOI":"10.3389\/fimmu.2021.658354","volume":"12","author":"N Gasaly","year":"2021","unstructured":"Gasaly N, de Vos P, Hermoso MA. Impact of bacterial metabolites on gut barrier function and host immunity: A focus on bacterial metabolism and its relevance for intestinal inflammation. Front Immunol. 2021;12:658354.","journal-title":"Front Immunol"},{"issue":"10","key":"1068_CR45","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1093\/carcin\/bgq070","volume":"31","author":"L Liu","year":"2010","unstructured":"Liu L, et al. An Apple oligogalactan prevents against inflammation and carcinogenesis by targeting LPS\/TLR4\/NF-kappaB pathway in a mouse model of colitis-associated colon cancer. Carcinogenesis. 2010;31(10):1822\u201332.","journal-title":"Carcinogenesis"},{"key":"1068_CR46","doi-asserted-by":"publisher","first-page":"758518","DOI":"10.3389\/fnut.2021.758518","volume":"8","author":"D Arnone","year":"2021","unstructured":"Arnone D, et al. Long-Term overconsumption of fat and sugar causes a partially reversible Pre-inflammatory bowel disease state. Front Nutr. 2021;8:758518.","journal-title":"Front Nutr"},{"issue":"5","key":"1068_CR47","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1136\/gutjnl-2013-305304","volume":"63","author":"AN Ananthakrishnan","year":"2014","unstructured":"Ananthakrishnan AN, et al. Long-term intake of dietary fat and risk of ulcerative colitis and crohn\u2019s disease. Gut. 2014;63(5):776\u201384.","journal-title":"Gut"},{"issue":"9","key":"1068_CR48","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1111\/j.1572-0241.2007.01411.x","volume":"102","author":"DK Amre","year":"2007","unstructured":"Amre DK, et al. Imbalances in dietary consumption of fatty acids, vegetables, and fruits are associated with risk for crohn\u2019s disease in children. Am J Gastroenterol. 2007;102(9):2016\u201325.","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"1068_CR49","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1159\/000121412","volume":"77","author":"AR Hart","year":"2008","unstructured":"Hart AR, et al. Diet in the aetiology of ulcerative colitis: a European prospective cohort study. Digestion. 2008;77(1):57\u201364.","journal-title":"Digestion"},{"issue":"4","key":"1068_CR50","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/ajg.2011.44","volume":"106","author":"JK Hou","year":"2011","unstructured":"Hou JK, Abraham B, El-Serag H. Dietary intake and risk of developing inflammatory bowel disease: a systematic review of the literature. Am J Gastroenterol. 2011;106(4):563\u201373.","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"1068_CR51","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1016\/j.jnutbio.2012.09.001","volume":"24","author":"EM van der Logt","year":"2013","unstructured":"van der Logt EM, et al. Westernized high-fat diet accelerates weight loss in dextran sulfate sodium-induced colitis in mice, which is further aggravated by supplementation of Heme. J Nutr Biochem. 2013;24(6):1159\u201365.","journal-title":"J Nutr Biochem"},{"issue":"10","key":"1068_CR52","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1038\/ajg.2010.192","volume":"105","author":"P Jantchou","year":"2010","unstructured":"Jantchou P, et al. Animal protein intake and risk of inflammatory bowel disease: the E3N prospective study. Am J Gastroenterol. 2010;105(10):2195\u2013201.","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"1068_CR53","first-page":"164","volume":"113","author":"XT Zhang","year":"2021","unstructured":"Zhang XT, He JP. Meta-analysis of protein intake on the effect of crohn\u2019s disease and ulcerative colitis. Rev Esp Enferm Dig. 2021;113(3):164\u20139.","journal-title":"Rev Esp Enferm Dig"},{"issue":"3","key":"1068_CR54","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.dld.2011.10.001","volume":"44","author":"V Andersen","year":"2012","unstructured":"Andersen V, et al. Diet and risk of inflammatory bowel disease. Dig Liver Dis. 2012;44(3):185\u201394.","journal-title":"Dig Liver Dis"},{"key":"1068_CR55","doi-asserted-by":"publisher","first-page":"n1554","DOI":"10.1136\/bmj.n1554","volume":"374","author":"N Narula","year":"2021","unstructured":"Narula N, et al. Association of ultra-processed food intake with risk of inflammatory bowel disease: prospective cohort study. BMJ. 2021;374:n1554.","journal-title":"BMJ"},{"key":"1068_CR56","doi-asserted-by":"crossref","unstructured":"Vidal-Lletj\u00f3s S et al. Dietary protein and amino acid supplementation in inflammatory bowel disease course: what impact on the colonic mucosa? Nutrients, 2017. 9(3).","DOI":"10.3390\/nu9030310"},{"issue":"3","key":"1068_CR57","first-page":"443","volume":"31","author":"XL Zhou","year":"2022","unstructured":"Zhou XL, et al. Protein intake and risk of inflammatory bowel disease: A meta-analysis. Asia Pac J Clin Nutr. 2022;31(3):443\u20139.","journal-title":"Asia Pac J Clin Nutr"},{"key":"1068_CR58","doi-asserted-by":"crossref","unstructured":"Sim\u00f5es CD, Maganinho M, Sousa AS. FODMAPs, inflammatory bowel disease and gut microbiota: updated overview on the current evidence. Eur J Nutr, 2022: pp. 1\u201312.","DOI":"10.1007\/s00394-021-02755-1"},{"issue":"5","key":"1068_CR59","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1097\/MIB.0000000000000708","volume":"22","author":"AC Prince","year":"2016","unstructured":"Prince AC, et al. Fermentable carbohydrate restriction (low FODMAP diet) in clinical practice improves functional Gastrointestinal symptoms in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2016;22(5):1129\u201336.","journal-title":"Inflamm Bowel Dis"},{"key":"1068_CR60","doi-asserted-by":"crossref","unstructured":"Gibson PR, Halmos EP. FODMAPs and carbohydrate intolerance. Clinical and basic neurogastroenterology and motility. Elsevier; 2020. pp. 371\u201386.","DOI":"10.1016\/B978-0-12-813037-7.00026-1"},{"issue":"10","key":"1068_CR61","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.3390\/nu14102072","volume":"14","author":"Z Peng","year":"2022","unstructured":"Peng Z, Yi J, Liu X. A Low-FODMAP diet provides benefits for functional Gastrointestinal symptoms but not for improving stool consistency and mucosal inflammation in IBD: A systematic review and Meta-Analysis. Nutrients. 2022;14(10):2072.","journal-title":"Nutrients"},{"issue":"18","key":"1068_CR62","doi-asserted-by":"publisher","first-page":"3356","DOI":"10.3748\/wjg.v23.i18.3356","volume":"23","author":"N Pedersen","year":"2017","unstructured":"Pedersen N, et al. Low-FODMAP diet reduces irritable bowel symptoms in patients with inflammatory bowel disease. World J Gastroenterol. 2017;23(18):3356.","journal-title":"World J Gastroenterol"},{"issue":"15","key":"1068_CR63","doi-asserted-by":"publisher","first-page":"4009","DOI":"10.3748\/wjg.v22.i15.4009","volume":"22","author":"L Maagaard","year":"2016","unstructured":"Maagaard L, et al. Follow-up of patients with functional bowel symptoms treated with a low FODMAP diet. World J Gastroenterol. 2016;22(15):4009.","journal-title":"World J Gastroenterol"},{"issue":"11","key":"1068_CR64","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.3390\/microorganisms8111638","volume":"8","author":"D Vandeputte","year":"2020","unstructured":"Vandeputte D, Joossens M. Effects of low and high FODMAP diets on human Gastrointestinal microbiota composition in adults with intestinal diseases: A systematic review. Microorganisms. 2020;8(11):1638.","journal-title":"Microorganisms"},{"issue":"12","key":"1068_CR65","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1016\/S2468-1253(20)30291-0","volume":"5","author":"H Strid","year":"2020","unstructured":"Strid H. Prevalence of IBS-type symptoms in IBD. Lancet Gastroenterol Hepatol. 2020;5(12):1029\u201331.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"1","key":"1068_CR66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1741-7015-12-112","volume":"12","author":"A Trichopoulou","year":"2014","unstructured":"Trichopoulou A, et al. Definitions and potential health benefits of the mediterranean diet: views from experts around the world. BMC Med. 2014;12(1):1\u201316.","journal-title":"BMC Med"},{"issue":"9","key":"1068_CR67","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/s41575-018-0022-9","volume":"15","author":"H Khalili","year":"2018","unstructured":"Khalili H, et al. The role of diet in the aetiopathogenesis of inflammatory bowel disease. Nat Reviews Gastroenterol Hepatol. 2018;15(9):525\u201335.","journal-title":"Nat Reviews Gastroenterol Hepatol"},{"key":"1068_CR68","doi-asserted-by":"crossref","unstructured":"Nagpal R et al. Gut microbiome-Mediterranean diet interactions in improving host health. F1000Research, 2019. 8.","DOI":"10.12688\/f1000research.18992.1"},{"key":"1068_CR69","unstructured":"Limketkai BN, et al. Dietary interventions for the treatment of inflammatory bowel diseases: an updated systematic review and meta-analysis. Clinical Gastroenterology and Hepatology; 2022."},{"key":"1068_CR70","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.clnesp.2021.09.726","volume":"46","author":"C Fiorindi","year":"2021","unstructured":"Fiorindi C, et al. Adherence to mediterranean diet in patients with inflammatory bowel disease. Clin Nutr ESPEN. 2021;46:416\u201323.","journal-title":"Clin Nutr ESPEN"},{"issue":"11","key":"1068_CR71","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1136\/gutjnl-2015-309957","volume":"65","author":"F De Filippis","year":"2016","unstructured":"De Filippis F, et al. High-level adherence to a mediterranean diet beneficially impacts the gut microbiota and associated metabolome. Gut. 2016;65(11):1812\u201321.","journal-title":"Gut"},{"issue":"1","key":"1068_CR72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ibd\/izaa097","volume":"27","author":"F Chicco","year":"2021","unstructured":"Chicco F, et al. Multidimensional impact of mediterranean diet on IBD patients. Inflamm Bowel Dis. 2021;27(1):1\u20139.","journal-title":"Inflamm Bowel Dis"},{"issue":"2","key":"1068_CR73","doi-asserted-by":"publisher","first-page":"171","DOI":"10.5217\/ir.2020.00035","volume":"19","author":"NH Shafiee","year":"2021","unstructured":"Shafiee NH, et al. Anti-inflammatory diet and inflammatory bowel disease: what clinicians and patients should know? Intestinal Res. 2021;19(2):171.","journal-title":"Intestinal Res"},{"issue":"1","key":"1068_CR74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1475-2891-13-5","volume":"13","author":"BC Olendzki","year":"2014","unstructured":"Olendzki BC, et al. An anti-inflammatory diet as treatment for inflammatory bowel disease: a case series report. Nutr J. 2014;13(1):1\u20137.","journal-title":"Nutr J"},{"key":"1068_CR75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1475-2891-13-5","volume":"13","author":"BC Olendzki","year":"2014","unstructured":"Olendzki BC, et al. An anti-inflammatory diet as treatment for inflammatory bowel disease: a case series report. Nutr J. 2014;13:1\u20137.","journal-title":"Nutr J"},{"issue":"1","key":"1068_CR76","doi-asserted-by":"publisher","first-page":"2046244","DOI":"10.1080\/19490976.2022.2046244","volume":"14","author":"B Olendzki","year":"2022","unstructured":"Olendzki B, et al. Dietary manipulation of the gut Microbiome in inflammatory bowel disease patients: pilot study. Gut Microbes. 2022;14(1):2046244.","journal-title":"Gut Microbes"},{"issue":"27","key":"1068_CR77","doi-asserted-by":"publisher","first-page":"3284","DOI":"10.3748\/wjg.v30.i27.3284","volume":"30","author":"A Rostami","year":"2024","unstructured":"Rostami A, White K, Rostami K. Pro and anti-inflammatory diets as strong epigenetic factors in inflammatory bowel disease. World J Gastroenterol. 2024;30(27):3284.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"1068_CR78","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.clnu.2018.01.020","volume":"38","author":"JJ Ashton","year":"2019","unstructured":"Ashton JJ, Gavin J, Beattie RM. Exclusive enteral nutrition in crohn\u2019s disease: evidence and practicalities. Clin Nutr. 2019;38(1):80\u20139.","journal-title":"Clin Nutr"},{"issue":"1","key":"1068_CR79","doi-asserted-by":"publisher","first-page":"212","DOI":"10.3390\/nu13010212","volume":"13","author":"CM Verburgt","year":"2021","unstructured":"Verburgt CM, et al. Nutritional therapy strategies in pediatric crohn\u2019s disease. Nutrients. 2021;13(1):212.","journal-title":"Nutrients"},{"issue":"10","key":"1068_CR80","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1016\/j.crohns.2014.04.005","volume":"8","author":"F Ruemmele","year":"2014","unstructured":"Ruemmele F, et al. Consensus guidelines of ECCO\/ESPGHAN on the medical management of pediatric crohn\u2019s disease. J Crohn\u2019s Colitis. 2014;8(10):1179\u2013207.","journal-title":"J Crohn\u2019s Colitis"},{"issue":"2","key":"1068_CR81","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s41110-022-00177-5","volume":"47","author":"HC Vidal","year":"2022","unstructured":"Vidal HC, Rogero MM. The use of exclusive enteral nutritional therapy in children and adolescents with active crohn\u2019s disease: an integrative review. Nutrire. 2022;47(2):25.","journal-title":"Nutrire"},{"issue":"7","key":"1068_CR82","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1093\/ecco-jcc\/jjy207","volume":"13","author":"B Pigneur","year":"2019","unstructured":"Pigneur B, et al. Mucosal healing and bacterial composition in response to enteral nutrition vs steroid-based induction therapy\u2014a randomised prospective clinical trial in children with crohn\u2019s disease. J Crohn\u2019s Colitis. 2019;13(7):846\u201355.","journal-title":"J Crohn\u2019s Colitis"},{"key":"1068_CR83","doi-asserted-by":"crossref","unstructured":"Sahu P, et al. Randomised clinical trial: exclusive enteral nutrition versus standard of care for acute severe ulcerative colitis. Volume 53. Alimentary Pharmacology & Therapeutics; 2021. pp. 568\u201376. 5.","DOI":"10.1111\/apt.16249"},{"key":"1068_CR84","doi-asserted-by":"crossref","unstructured":"Rubio A, et al. The efficacy of exclusive nutritional therapy in paediatric crohn\u2019s disease, comparing fractionated oral vs. continuous enteral feeding. Volume 33. Alimentary pharmacology & therapeutics; 2011. pp. 1332\u20139. 12.","DOI":"10.1111\/j.1365-2036.2011.04662.x"},{"issue":"11","key":"1068_CR85","doi-asserted-by":"publisher","first-page":"4112","DOI":"10.3390\/nu13114112","volume":"13","author":"M Szczube\u0142ek","year":"2021","unstructured":"Szczube\u0142ek M, et al. Effectiveness of crohn\u2019s disease exclusion diet for induction of remission in crohn\u2019s disease adult patients. Nutrients. 2021;13(11):4112.","journal-title":"Nutrients"},{"issue":"2","key":"1068_CR86","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1053\/j.gastro.2019.04.021","volume":"157","author":"A Levine","year":"2019","unstructured":"Levine A, et al. Crohn\u2019s disease exclusion diet plus partial enteral nutrition induces sustained remission in a randomized controlled trial. Gastroenterology. 2019;157(2):440\u201350. e8.","journal-title":"Gastroenterology"},{"issue":"10","key":"1068_CR87","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1093\/ecco-jcc\/jjx071","volume":"11","author":"R Sigall Boneh","year":"2017","unstructured":"Sigall Boneh R, et al. Dietary therapy with the crohn\u2019s disease exclusion diet is a successful strategy for induction of remission in children and adults failing biological therapy. J Crohn\u2019s Colitis. 2017;11(10):1205\u201312.","journal-title":"J Crohn\u2019s Colitis"},{"issue":"4","key":"1068_CR88","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.cgh.2020.04.006","volume":"19","author":"RS Boneh","year":"2021","unstructured":"Boneh RS, et al. Dietary therapies induce rapid response and remission in pediatric patients with active crohn\u2019s disease. Clin Gastroenterol Hepatol. 2021;19(4):752\u20139.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"1068_CR89","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1053\/j.gastro.2022.05.050","volume":"163","author":"M Ghiboub","year":"2022","unstructured":"Ghiboub M, et al. Metabolome changes with diet-induced remission in pediatric crohn\u2019s disease. Gastroenterology. 2022;163(4):922\u201336. e15.","journal-title":"Gastroenterology"},{"key":"1068_CR90","doi-asserted-by":"crossref","unstructured":"Svolos, V., et al., Treatment of Active Crohn\u2019s Disease With an Ordinary Food-based Diet That Replicates Exclusive Enteral Nutrition. Gastroenterology, 2019. 156(5): pp. 1354\u20131367.e6.","DOI":"10.1053\/j.gastro.2018.12.002"},{"issue":"1","key":"1068_CR91","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1136\/gutjnl-2018-317987","volume":"69","author":"D Turner","year":"2020","unstructured":"Turner D, et al. Designing clinical trials in paediatric inflammatory bowel diseases: a PIBDnet commentary. Gut. 2020;69(1):32\u201341.","journal-title":"Gut"},{"issue":"2","key":"1068_CR92","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.clinre.2017.09.002","volume":"42","author":"G Wang","year":"2018","unstructured":"Wang G, et al. The utility of food antigen test in the diagnosis of crohn\u2019s disease and remission maintenance after exclusive enteral nutrition. Clin Res Hepatol Gastroenterol. 2018;42(2):145\u201352.","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"5","key":"1068_CR93","doi-asserted-by":"publisher","first-page":"408","DOI":"10.5152\/tjg.2019.18466","volume":"30","author":"HS Lee","year":"2019","unstructured":"Lee HS, Lee KJ. Immunoglobulin G4-related immune responses to common food antigens in patients with ulcerative colitis and crohn\u2019s disease. Turkish J Gastroenterol. 2019;30(5):408.","journal-title":"Turkish J Gastroenterol"},{"key":"1068_CR94","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1007\/s10620-015-3987-z","volume":"61","author":"V Gunasekeera","year":"2016","unstructured":"Gunasekeera V, et al. Treatment of crohn\u2019s disease with an IgG4-guided exclusion diet: a randomized controlled trial. Dig Dis Sci. 2016;61:1148\u201357.","journal-title":"Dig Dis Sci"},{"issue":"9","key":"1068_CR95","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1111\/j.1463-1318.2010.02373.x","volume":"13","author":"N Rajendran","year":"2011","unstructured":"Rajendran N, Kumar D. Food-specific IgG4\u2010guided exclusion diets improve symptoms in crohn\u2019s disease: a pilot study. Colorectal Dis. 2011;13(9):1009\u201313.","journal-title":"Colorectal Dis"},{"issue":"9","key":"1068_CR96","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1093\/ibd\/izy110","volume":"24","author":"L Jian","year":"2018","unstructured":"Jian L, et al. Food exclusion based on IgG antibodies alleviates symptoms in ulcerative colitis: a prospective study. Inflamm Bowel Dis. 2018;24(9):1918\u201325.","journal-title":"Inflamm Bowel Dis"},{"issue":"4","key":"1068_CR97","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.gtc.2017.08.011","volume":"46","author":"FK Ghishan","year":"2017","unstructured":"Ghishan FK, Kiela PR. Vitamins and minerals in inflammatory bowel disease. Gastroenterol Clin. 2017;46(4):797\u2013808.","journal-title":"Gastroenterol Clin"},{"issue":"13","key":"1068_CR98","doi-asserted-by":"publisher","first-page":"3542","DOI":"10.3748\/wjg.v20.i13.3542","volume":"20","author":"D Guagnozzi","year":"2014","unstructured":"Guagnozzi D, Lucendo AJ. Anemia in inflammatory bowel disease: a neglected issue with relevant effects. World J Gastroenterology: WJG. 2014;20(13):3542.","journal-title":"World J Gastroenterology: WJG"},{"issue":"2","key":"1068_CR99","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1056\/NEJMcp1113996","volume":"368","author":"SP Stabler","year":"2013","unstructured":"Stabler SP. Vitamin B12 deficiency. N Engl J Med. 2013;368(2):149\u201360.","journal-title":"N Engl J Med"},{"issue":"6","key":"1068_CR100","first-page":"1120","volume":"20","author":"R Battat","year":"2014","unstructured":"Battat R, et al. Vitamin B12 deficiency in inflammatory bowel disease: prevalence, risk factors, evaluation, and management. Inflamm Bowel Dis. 2014;20(6):1120\u20138.","journal-title":"Inflamm Bowel Dis"},{"key":"1068_CR101","doi-asserted-by":"crossref","unstructured":"Pan Y et al. Associations between folate and vitamin B12 levels and inflammatory bowel disease: A Meta-Analysis. Nutrients, 2017. 9(4).","DOI":"10.3390\/nu9040382"},{"issue":"4","key":"1068_CR102","doi-asserted-by":"publisher","first-page":"382","DOI":"10.3390\/nu9040382","volume":"9","author":"Y Pan","year":"2017","unstructured":"Pan Y, et al. Associations between folate and vitamin B12 levels and inflammatory bowel disease: a meta-analysis. Nutrients. 2017;9(4):382.","journal-title":"Nutrients"},{"issue":"2","key":"1068_CR103","doi-asserted-by":"publisher","first-page":"145","DOI":"10.7861\/clinmedicine.15-2-145","volume":"15","author":"MJ Shipton","year":"2015","unstructured":"Shipton MJ, Thachil J. Vitamin B12 deficiency\u2013A 21st century perspective. Clin Med. 2015;15(2):145.","journal-title":"Clin Med"},{"issue":"9","key":"1068_CR104","doi-asserted-by":"publisher","first-page":"16","DOI":"10.12968\/gasn.2017.15.9.16","volume":"15","author":"J Fletcher","year":"2017","unstructured":"Fletcher J, Swift A. Vitamin D screening in patients with inflammatory bowel disease. Gastrointest Nurs. 2017;15(9):16\u201323.","journal-title":"Gastrointest Nurs"},{"issue":"4","key":"1068_CR105","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.crohns.2012.01.007","volume":"6","author":"I Nicholson","year":"2012","unstructured":"Nicholson I, Dalzell AM, El-Matary W. Vitamin D as a therapy for colitis: a systematic review. J Crohn\u2019s Colitis. 2012;6(4):405\u201311.","journal-title":"J Crohn\u2019s Colitis"},{"issue":"2","key":"1068_CR106","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1039\/C4FO00579A","volume":"6","author":"E Reboul","year":"2015","unstructured":"Reboul E. Intestinal absorption of vitamin D: from the meal to the enterocyte. Food Funct. 2015;6(2):356\u201362.","journal-title":"Food Funct"},{"issue":"5","key":"1068_CR107","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.3390\/nu11051019","volume":"11","author":"J Fletcher","year":"2019","unstructured":"Fletcher J, et al. The role of vitamin D in inflammatory bowel disease: mechanism to management. Nutrients. 2019;11(5):1019.","journal-title":"Nutrients"},{"issue":"9","key":"1068_CR108","first-page":"1921","volume":"19","author":"AN Ananthakrishnan","year":"2013","unstructured":"Ananthakrishnan AN, et al. Normalization of plasma 25-hydroxy vitamin D is associated with reduced risk of surgery in crohn\u2019s disease. Inflamm Bowel Dis. 2013;19(9):1921\u20137.","journal-title":"Inflamm Bowel Dis"},{"issue":"8","key":"1068_CR109","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1093\/ecco-jcc\/jjy052","volume":"12","author":"M Garg","year":"2018","unstructured":"Garg M, et al. The effect of vitamin D on intestinal inflammation and faecal microbiota in patients with ulcerative colitis. J Crohn\u2019s Colitis. 2018;12(8):963\u201372.","journal-title":"J Crohn\u2019s Colitis"},{"key":"1068_CR110","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.jcol.2015.06.004","volume":"35","author":"A Fialho","year":"2015","unstructured":"Fialho A, et al. Association between vitamin D deficiency and anemia in inflammatory bowel disease patients with ileostomy. J Coloproctology (Rio De Janeiro). 2015;35:139\u201345.","journal-title":"J Coloproctology (Rio De Janeiro)"},{"issue":"3","key":"1068_CR111","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1177\/0148607113504002","volume":"38","author":"ZA Zator","year":"2014","unstructured":"Zator ZA, et al. Pretreatment 25-hydroxyvitamin D levels and durability of anti\u2013tumor necrosis factor\u2013\u03b1 therapy in inflammatory bowel diseases. J Parenter Enter Nutr. 2014;38(3):385\u201391.","journal-title":"J Parenter Enter Nutr"},{"key":"1068_CR112","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1023\/B:DDAS.0000017460.90887.11","volume":"49","author":"M Stio","year":"2004","unstructured":"Stio M, et al. Effect of anti-TNF therapy and vitamin D derivatives on the proliferation of peripheral blood mononuclear cells in crohn\u2019s disease. Dig Dis Sci. 2004;49:328\u201335.","journal-title":"Dig Dis Sci"},{"key":"1068_CR113","doi-asserted-by":"crossref","unstructured":"Krishnamoorthy R, Jeanes Y. PWE-115 dietary patterns in inflammatory bowel disease-intolerances, quality of life and calcium\/vitamin D intake. BMJ Publishing Group; 2018.","DOI":"10.1136\/gutjnl-2018-BSGAbstracts.349"},{"issue":"17","key":"1068_CR114","doi-asserted-by":"publisher","first-page":"7588","DOI":"10.1039\/D1FO00613D","volume":"12","author":"Y Guo","year":"2021","unstructured":"Guo Y, et al. Effects of oral vitamin D supplementation on inflammatory bowel disease: A systematic review and meta-analysis. Food Funct. 2021;12(17):7588\u2013606.","journal-title":"Food Funct"},{"issue":"6","key":"1068_CR115","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.3945\/ajcn.111.031070","volume":"95","author":"L Tripkovic","year":"2012","unstructured":"Tripkovic L, et al. Comparison of vitamin D2 and vitamin D3 supplementation in Raising serum 25-hydroxyvitamin D status: a systematic review and meta-analysis. Am J Clin Nutr. 2012;95(6):1357\u201364.","journal-title":"Am J Clin Nutr"},{"issue":"4","key":"1068_CR116","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1136\/flgastro-2018-101055","volume":"10","author":"OH Nielsen","year":"2019","unstructured":"Nielsen OH, et al. Managing vitamin D deficiency in inflammatory bowel disease. Frontline Gastroenterol. 2019;10(4):394\u2013400.","journal-title":"Frontline Gastroenterol"},{"issue":"Suppl 2","key":"1068_CR117","doi-asserted-by":"publisher","first-page":"s1","DOI":"10.1136\/gutjnl-2024-334395","volume":"74","author":"GW Moran","year":"2025","unstructured":"Moran GW, et al. British society of gastroenterology guidelines on inflammatory bowel disease in adults: 2025. Gut. 2025;74(Suppl 2):s1\u2013101.","journal-title":"Gut"},{"issue":"3","key":"1068_CR118","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1053\/j.gastro.2023.11.303","volume":"166","author":"JG Hashash","year":"2024","unstructured":"Hashash JG, et al. AGA clinical practice update on diet and nutritional therapies in patients with inflammatory bowel disease: expert review. Gastroenterology. 2024;166(3):521\u201332.","journal-title":"Gastroenterology"},{"issue":"8","key":"1068_CR119","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1111\/j.1572-0241.2002.05916.x","volume":"97","author":"D De Jong","year":"2002","unstructured":"De Jong D, et al. Corticosteroid-induced osteoporosis: does it occur in patients with crohn\u2019s disease? Am J Gastroenterol. 2002;97(8):2011\u20135.","journal-title":"Am J Gastroenterol"},{"key":"1068_CR120","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1002\/1529-0131(200107)44:7<1496::AID-ART271>3.0.CO;2-5","volume":"44","author":"L Buckley","year":"2001","unstructured":"Buckley L. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis 2001 update American college of rheumatology ad hoc committee on Glucocorticoid-Induced osteoporosis. Arthritis Rheum. 2001;44:1496\u2013503.","journal-title":"Arthritis Rheum"},{"issue":"4","key":"1068_CR121","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.crohns.2013.09.008","volume":"8","author":"P Vernia","year":"2014","unstructured":"Vernia P, et al. Dietary calcium intake in patients with inflammatory bowel disease. J Crohn\u2019s Colitis. 2014;8(4):312\u20137.","journal-title":"J Crohn\u2019s Colitis"},{"issue":"1","key":"1068_CR122","doi-asserted-by":"publisher","first-page":"7913","DOI":"10.1038\/s41598-022-11597-8","volume":"12","author":"Z Hajhashemy","year":"2022","unstructured":"Hajhashemy Z, et al. A population based case\u2013control study of association between dietary calcium intake and ulcerative colitis in adults. Sci Rep. 2022;12(1):7913.","journal-title":"Sci Rep"},{"issue":"5454","key":"1068_CR123","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1136\/bmj.2.5454.138","volume":"2","author":"R Wright","year":"1965","unstructured":"Wright R, Truelove S. A controlled therapeutic trial of various diets in ulcerative colitis. BMJ. 1965;2(5454):138.","journal-title":"BMJ"},{"key":"1068_CR124","unstructured":"Bernstein CN et al. Milk tolerance in adults with ulcerative colitis. Am J Gastroenterol (Springer Nature), 1994. 89(6)."},{"issue":"3","key":"1068_CR125","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1053\/j.gastro.2011.11.040","volume":"142","author":"AN Ananthakrishnan","year":"2012","unstructured":"Ananthakrishnan AN, et al. Higher predicted vitamin D status is associated with reduced risk of crohn\u2019s disease. Gastroenterology. 2012;142(3):482\u20139.","journal-title":"Gastroenterology"},{"issue":"7","key":"1068_CR126","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1002\/mnfr.201400569","volume":"59","author":"MS Da Silva","year":"2015","unstructured":"Da Silva MS, Rudkowska I. Dairy nutrients and their effect on inflammatory profile in molecular studies. Mol Nutr Food Res. 2015;59(7):1249\u201363.","journal-title":"Mol Nutr Food Res"},{"issue":"5","key":"1068_CR127","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1136\/gut.2006.117382","volume":"57","author":"H Tilg","year":"2008","unstructured":"Tilg H, et al. Gut, inflammation and osteoporosis: basic and clinical concepts. Gut. 2008;57(5):684\u201394.","journal-title":"Gut"},{"issue":"1","key":"1068_CR128","first-page":"Cd013529","volume":"1","author":"M Gordon","year":"2021","unstructured":"Gordon M, et al. Interventions for treating iron deficiency anaemia in inflammatory bowel disease. Cochrane Database Syst Rev. 2021;1(1):Cd013529.","journal-title":"Cochrane Database Syst Rev"},{"key":"1068_CR129","doi-asserted-by":"publisher","first-page":"686778","DOI":"10.3389\/fmed.2021.686778","volume":"8","author":"T Res\u00e1l","year":"2021","unstructured":"Res\u00e1l T, Farkas K, Moln\u00e1r T. Iron deficiency anemia in inflammatory bowel disease: what do we know? Front Med. 2021;8:686778.","journal-title":"Front Med"},{"key":"1068_CR130","doi-asserted-by":"publisher","first-page":"175628481876907","DOI":"10.1177\/1756284818769074","volume":"11","author":"D Niepel","year":"2018","unstructured":"Niepel D, et al. Practical guidance for the management of iron deficiency in patients with inflammatory bowel disease. Therapeutic Adv Gastroenterol. 2018;11:1756284818769074.","journal-title":"Therapeutic Adv Gastroenterol"},{"issue":"2","key":"1068_CR131","doi-asserted-by":"publisher","first-page":"AB251","DOI":"10.1016\/j.jaci.2014.12.1760","volume":"135","author":"E Feuille","year":"2015","unstructured":"Feuille E, et al. Inflammatory bowel disease and food allergies. J Allergy Clin Immunol. 2015;135(2):AB251.","journal-title":"J Allergy Clin Immunol"},{"issue":"8","key":"1068_CR132","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1136\/gut.2003.035758","volume":"53","author":"C Gasche","year":"2004","unstructured":"Gasche C, et al. Iron, anaemia, and inflammatory bowel diseases. Gut. 2004;53(8):1190.","journal-title":"Gut"},{"issue":"3","key":"1068_CR133","doi-asserted-by":"publisher","first-page":"62","DOI":"10.4291\/wjgp.v6.i3.62","volume":"6","author":"S Kaitha","year":"2015","unstructured":"Kaitha S, Bashir M, Ali T. Iron deficiency anemia in inflammatory bowel disease. World J Gastrointest Pathophysiol. 2015;6(3):62\u201372.","journal-title":"World J Gastrointest Pathophysiol"},{"issue":"8","key":"1068_CR134","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1097\/MCG.0000000000000417","volume":"50","author":"IE Koutroubakis","year":"2016","unstructured":"Koutroubakis IE, et al. Five-year period prevalence and characteristics of anemia in a large US inflammatory bowel disease cohort. J Clin Gastroenterol. 2016;50(8):638.","journal-title":"J Clin Gastroenterol"},{"issue":"1","key":"1068_CR135","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12876-021-01826-1","volume":"21","author":"K Foteinogiannopoulou","year":"2021","unstructured":"Foteinogiannopoulou K, et al. The burden and management of anemia in Greek patients with inflammatory bowel disease: A retrospective, multicenter, observational study. BMC Gastroenterol. 2021;21(1):1\u201310.","journal-title":"BMC Gastroenterol"},{"issue":"1","key":"1068_CR136","doi-asserted-by":"publisher","first-page":"e000155","DOI":"10.1136\/bmjgast-2017-000155","volume":"4","author":"E Akhuemonkhan","year":"2017","unstructured":"Akhuemonkhan E, et al. Prevalence and screening for anaemia in mild to moderate crohn\u2019s disease and ulcerative colitis in the united States, 2010\u20132014. BMJ Open Gastroenterol. 2017;4(1):e000155.","journal-title":"BMJ Open Gastroenterol"},{"issue":"3","key":"1068_CR137","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1093\/ecco-jcc\/jju009","volume":"9","author":"AU Dignass","year":"2015","unstructured":"Dignass AU, et al. European consensus on the diagnosis and management of iron deficiency and anaemia in inflammatory bowel diseases. J Crohn\u2019s Colitis. 2015;9(3):211\u201322.","journal-title":"J Crohn\u2019s Colitis"},{"issue":"3","key":"1068_CR138","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.crohns.2011.09.010","volume":"6","author":"TW Lee","year":"2012","unstructured":"Lee TW, et al. Iron replacement therapy in inflammatory bowel disease patients with iron deficiency anemia: a systematic review and meta-analysis. J Crohn\u2019s Colitis. 2012;6(3):267\u201375.","journal-title":"J Crohn\u2019s Colitis"},{"issue":"2","key":"1068_CR139","doi-asserted-by":"publisher","first-page":"e0117383","DOI":"10.1371\/journal.pone.0117383","volume":"10","author":"Z Tolkien","year":"2015","unstructured":"Tolkien Z, et al. Ferrous sulfate supplementation causes significant Gastrointestinal side-effects in adults: a systematic review and meta-analysis. PLoS ONE. 2015;10(2):e0117383.","journal-title":"PLoS ONE"},{"issue":"7","key":"1068_CR140","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1080\/00365520902839667","volume":"44","author":"S Lindgren","year":"2009","unstructured":"Lindgren S, et al. Intravenous iron sucrose is superior to oral iron sulphate for correcting anaemia and restoring iron stores in IBD patients: a randomized, controlled, evaluator-blind, multicentre study. Scand J Gastroenterol. 2009;44(7):838\u201345.","journal-title":"Scand J Gastroenterol"},{"issue":"11","key":"1068_CR141","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1111\/j.1572-0241.2005.00250.x","volume":"100","author":"O Schr\u00f6der","year":"2005","unstructured":"Schr\u00f6der O, et al. Intravenous iron sucrose versus oral iron supplementation for the treatment of iron deficiency anemia in patients with inflammatory bowel disease\u2014a randomized, controlled, open-label, multicenter study. Official J Am Coll Gastroenterology| ACG. 2005;100(11):2503\u20139.","journal-title":"Official J Am Coll Gastroenterology| ACG"},{"issue":"8","key":"1068_CR142","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.1111\/j.1572-0241.2001.04094.x","volume":"96","author":"C Gasche","year":"2001","unstructured":"Gasche C, et al. Prediction of response to iron sucrose in inflammatory bowel disease-associated anemia. Am J Gastroenterol. 2001;96(8):2382\u20137.","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"1068_CR143","first-page":"15","volume":"30","author":"V M\u00fccke","year":"2017","unstructured":"M\u00fccke V, et al. Diagnosis and treatment of anemia in patients with inflammatory bowel disease. Annals Gastroenterology: Q Publication Hellenic Soc Gastroenterol. 2017;30(1):15.","journal-title":"Annals Gastroenterology: Q Publication Hellenic Soc Gastroenterol"},{"issue":"9","key":"1068_CR144","doi-asserted-by":"publisher","first-page":"3190","DOI":"10.1007\/s12011-020-02444-w","volume":"199","author":"M Vaghari-Tabari","year":"2021","unstructured":"Vaghari-Tabari M, et al. Zinc and selenium in inflammatory bowel disease: trace elements with key roles? Biol Trace Elem Res. 2021;199(9):3190\u2013204.","journal-title":"Biol Trace Elem Res"},{"issue":"1","key":"1068_CR145","doi-asserted-by":"publisher","first-page":"78","DOI":"10.5217\/ir.2020.00124","volume":"20","author":"K Sakurai","year":"2022","unstructured":"Sakurai K, et al. Effectiveness of administering zinc acetate hydrate to patients with inflammatory bowel disease and zinc deficiency: a retrospective observational two-center study. Intest Res. 2022;20(1):78\u201389.","journal-title":"Intest Res"},{"key":"1068_CR146","doi-asserted-by":"publisher","unstructured":"Kilby K, et al. Micronutrient absorption and related outcomes in people with inflammatory bowel disease: A review. Nutrients. 2019;11. https:\/\/doi.org\/10.3390\/nu11061388.","DOI":"10.3390\/nu11061388"},{"issue":"6","key":"1068_CR147","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1093\/ije\/dyv301","volume":"44","author":"AN Ananthakrishnan","year":"2015","unstructured":"Ananthakrishnan AN, et al. Zinc intake and risk of crohn\u2019s disease and ulcerative colitis: a prospective cohort study. Int J Epidemiol. 2015;44(6):1995\u20132005.","journal-title":"Int J Epidemiol"},{"issue":"3","key":"1068_CR148","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1097\/01.MIB.0000206541.15963.c3","volume":"12","author":"J Filippi","year":"2006","unstructured":"Filippi J, et al. Nutritional deficiencies in patients with crohn\u2019s disease in remission. Inflamm Bowel Dis. 2006;12(3):185\u201391.","journal-title":"Inflamm Bowel Dis"},{"issue":"3","key":"1068_CR149","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1177\/0148607114549254","volume":"40","author":"K Vagianos","year":"2016","unstructured":"Vagianos K, et al. What are adults with inflammatory bowel disease (IBD) eating? A closer look at the dietary habits of a population-based Canadian IBD cohort. J Parenter Enter Nutr. 2016;40(3):405\u201311.","journal-title":"J Parenter Enter Nutr"},{"key":"1068_CR150","doi-asserted-by":"crossref","unstructured":"Lambert K, et al. Systematic review with meta-analysis: dietary intake in adults with inflammatory bowel disease. Alimentary Pharmacology & Therapeutics; 2021. p. 54.","DOI":"10.1111\/apt.16549"},{"issue":"4","key":"1068_CR151","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1097\/TIN.0000000000000261","volume":"36","author":"M Zhang","year":"2021","unstructured":"Zhang M, et al. Zinc level in pathogenesis of inflammatory bowel disease: A systematic review and Meta-analysis. Top Clin Nutr. 2021;36(4):319\u201330.","journal-title":"Top Clin Nutr"},{"key":"1068_CR152","doi-asserted-by":"crossref","unstructured":"Zupo R et al. Prevalence of Zinc Deficiency in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. Nutrients, 2022. 14(19).","DOI":"10.3390\/nu14194052"},{"key":"1068_CR153","doi-asserted-by":"publisher","unstructured":"Kodama H, et al. Japan\u2019s practical guidelines for zinc deficiency with a particular focus on taste Disorders, inflammatory bowel Disease, and liver cirrhosis. Int J Mol Sci. 2020;21. https:\/\/doi.org\/10.3390\/ijms21082941.","DOI":"10.3390\/ijms21082941"},{"issue":"4","key":"1068_CR154","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1053\/j.gastro.2014.06.024","volume":"147","author":"A Lahiri","year":"2014","unstructured":"Lahiri A, Abraham C. Activation of pattern recognition receptors up-regulates metallothioneins, thereby increasing intracellular accumulation of zinc, autophagy, and bacterial clearance by macrophages. Gastroenterology. 2014;147(4):835\u201346.","journal-title":"Gastroenterology"},{"key":"1068_CR155","doi-asserted-by":"crossref","unstructured":"Vela G et al. Zinc in gut-brain interaction in autism and neurological disorders. Neural plasticity, 2015.","DOI":"10.1155\/2015\/972791"},{"issue":"9","key":"1068_CR156","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1093\/jn\/138.9.1664","volume":"138","author":"A Finamore","year":"2008","unstructured":"Finamore A, et al. Zinc deficiency induces membrane barrier damage and increases neutrophil transmigration in Caco-2 cells. J Nutr. 2008;138(9):1664\u201370.","journal-title":"J Nutr"},{"issue":"1","key":"1068_CR157","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1097\/MIB.0000000000000989","volume":"23","author":"S Siva","year":"2017","unstructured":"Siva S, et al. Zinc deficiency is associated with poor clinical outcomes in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2017;23(1):152\u20137.","journal-title":"Inflamm Bowel Dis"},{"issue":"3","key":"1068_CR158","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.phanu.2018.06.004","volume":"6","author":"NRM Soares","year":"2018","unstructured":"Soares NRM, et al. Zinc supplementation reduces inflammation in ulcerative colitis patients by downregulating gene expression of Zn metalloproteins. PharmaNutrition. 2018;6(3):119\u201324.","journal-title":"PharmaNutrition"},{"issue":"2","key":"1068_CR159","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1097\/00054725-200105000-00003","volume":"7","author":"GC Sturniolo","year":"2001","unstructured":"Sturniolo GC, et al. Zinc supplementation tightens leaky gut in crohn\u2019s disease. Inflamm Bowel Dis. 2001;7(2):94\u20138.","journal-title":"Inflamm Bowel Dis"},{"key":"1068_CR160","unstructured":"Raymond JL, Morrow K. Krause and Mahan\u2019s Food and the Nutrition Care Process. Elsevier; 2020."},{"key":"1068_CR161","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.redox.2015.10.006","volume":"6","author":"FA Moura","year":"2015","unstructured":"Moura FA, et al. Antioxidant therapy for treatment of inflammatory bowel disease: does it work? Redox Biol. 2015;6:617\u201339.","journal-title":"Redox Biol"},{"issue":"1","key":"1068_CR162","doi-asserted-by":"publisher","first-page":"3","DOI":"10.4103\/1319-3767.173753","volume":"22","author":"IM Balmus","year":"2016","unstructured":"Balmus IM, et al. The implications of oxidative stress and antioxidant therapies in inflammatory bowel disease: clinical aspects and animal models. Saudi J Gastroenterology: Official J Saudi Gastroenterol Association. 2016;22(1):3.","journal-title":"Saudi J Gastroenterology: Official J Saudi Gastroenterol Association"},{"key":"1068_CR163","doi-asserted-by":"crossref","unstructured":"Guan G, Lan S. Implications of antioxidant systems in inflammatory bowel disease. BioMed research international, 2018. 2018.","DOI":"10.1155\/2018\/1290179"},{"issue":"10","key":"1068_CR164","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1089\/ars.2017.7083","volume":"27","author":"MM Cortese-Krott","year":"2017","unstructured":"Cortese-Krott MM, et al. The reactive species interactome: evolutionary emergence, biological significance, and opportunities for redox metabolomics and personalized medicine. Antioxid Redox Signal. 2017;27(10):684\u2013712.","journal-title":"Antioxid Redox Signal"},{"issue":"11","key":"1068_CR165","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1016\/j.molmed.2020.06.006","volume":"26","author":"AR Bourgonje","year":"2020","unstructured":"Bourgonje AR, et al. Oxidative stress and Redox-Modulating therapeutics in inflammatory bowel disease. Trends Mol Med. 2020;26(11):1034\u201346.","journal-title":"Trends Mol Med"},{"key":"1068_CR166","doi-asserted-by":"publisher","unstructured":"Dzi\u0105bowska-Grabias K, et al. Antioxidant therapy in inflammatory bowel diseases. Antioxidants. 2021;10. https:\/\/doi.org\/10.3390\/antiox10030412.","DOI":"10.3390\/antiox10030412"},{"issue":"2","key":"1068_CR167","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1111\/j.1572-0241.2003.07226.x","volume":"98","author":"E Aghdassi","year":"2003","unstructured":"Aghdassi E, et al. Antioxidant vitamin supplementation in crohn\u2019s disease decreases oxidative stress: a randomized controlled trial. Am J Gastroenterol. 2003;98(2):348\u201353.","journal-title":"Am J Gastroenterol"},{"issue":"18","key":"1068_CR168","doi-asserted-by":"publisher","first-page":"2851","DOI":"10.3748\/wjg.14.2851","volume":"14","author":"LG Guijarro","year":"2008","unstructured":"Guijarro LG, et al. N-acetyl-L-cysteine combined with Mesalamine in the treatment of ulcerative colitis: randomized, placebo-controlled pilot study. World J Gastroenterology: WJG. 2008;14(18):2851.","journal-title":"World J Gastroenterology: WJG"},{"issue":"1","key":"1068_CR169","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.ejphar.2012.06.014","volume":"691","author":"I Amrouche-Mekkioui","year":"2012","unstructured":"Amrouche-Mekkioui I, Djerdjouri B. N-acetylcysteine improves redox status, mitochondrial dysfunction, mucin-depleted crypts and epithelial hyperplasia in dextran sulfate sodium-induced oxidative colitis in mice. Eur J Pharmacol. 2012;691(1):209\u201317.","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"1068_CR170","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1079\/BJN20051466","volume":"94","author":"TM Trebble","year":"2005","unstructured":"Trebble TM, et al. High-dose fish oil and antioxidants in crohn\u2019s disease and the response of bone turnover: a randomised controlled trial. Br J Nutr. 2005;94(2):253\u201361.","journal-title":"Br J Nutr"},{"issue":"6","key":"1068_CR171","doi-asserted-by":"publisher","first-page":"2352","DOI":"10.1002\/ptr.7454","volume":"36","author":"E Nattagh-Eshtivani","year":"2022","unstructured":"Nattagh-Eshtivani E, et al. The role of pycnogenol in the control of inflammation and oxidative stress in chronic diseases: molecular aspects. Phytother Res. 2022;36(6):2352\u201374.","journal-title":"Phytother Res"},{"issue":"8","key":"1068_CR172","doi-asserted-by":"publisher","first-page":"624","DOI":"10.3109\/10715762.2013.807508","volume":"47","author":"M Kol\u00e1\u010dek","year":"2013","unstructured":"Kol\u00e1\u010dek M, et al. Effect of natural polyphenols (Pycnogenol) on oxidative stress markers in children suffering from crohn\u2019s disease\u2013a pilot study. Free Radic Res. 2013;47(8):624\u201334.","journal-title":"Free Radic Res"},{"issue":"12","key":"1068_CR173","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1007\/s11655-012-1026-x","volume":"21","author":"M Rastegarpanah","year":"2015","unstructured":"Rastegarpanah M, et al. A randomized, double blinded, placebo-controlled clinical trial of Silymarin in ulcerative colitis. Chin J Integr Med. 2015;21(12):902\u20136.","journal-title":"Chin J Integr Med"},{"issue":"11","key":"1068_CR174","first-page":"811","volume":"89","author":"DM Abdallah","year":"2011","unstructured":"Abdallah DM, Ismael NR. Resveratrol abrogates adhesion molecules and protects against TNBS-induced ulcerative colitis in rats. Can J Physiol Pharmacol. 2011;89(11):811\u20138.","journal-title":"Can J Physiol Pharmacol"},{"issue":"4","key":"1068_CR175","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1002\/ibd.21843","volume":"18","author":"K Rahal","year":"2012","unstructured":"Rahal K, et al. Resveratrol has antiinflammatory and antifibrotic effects in the peptidoglycan-polysaccharide rat model of crohn\u2019s disease. Inflamm Bowel Dis. 2012;18(4):613\u201323.","journal-title":"Inflamm Bowel Dis"},{"issue":"4","key":"1068_CR176","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.arcmed.2016.07.003","volume":"47","author":"M Samsamikor","year":"2016","unstructured":"Samsamikor M, et al. Resveratrol supplementation and oxidative\/anti-oxidative status in patients with ulcerative colitis: a randomized, double-blind, placebo-controlled pilot study. Arch Med Res. 2016;47(4):304\u20139.","journal-title":"Arch Med Res"},{"issue":"02","key":"1068_CR177","first-page":"102","volume":"29","author":"Z Zeng","year":"2013","unstructured":"Zeng Z, et al. Curcumin improves TNBS-induced colitis in rats by inhibiting IL-27 expression via the TLR4\/NF-\u03baB signaling pathway. Planta Med. 2013;29(02):102\u20139.","journal-title":"Planta Med"},{"key":"1068_CR178","doi-asserted-by":"publisher","first-page":"455","DOI":"10.3389\/fphar.2016.00455","volume":"7","author":"H-M Zhao","year":"2016","unstructured":"Zhao H-M, et al. Curcumin suppressed activation of dendritic cells via JAK\/STAT\/SOCS signal in mice with experimental colitis. Front Pharmacol. 2016;7:455.","journal-title":"Front Pharmacol"},{"issue":"1","key":"1068_CR179","doi-asserted-by":"publisher","first-page":"18","DOI":"10.15430\/JCP.2018.23.1.18","volume":"23","author":"J-y Yang","year":"2018","unstructured":"Yang J-y, et al. Comparative effects of Curcumin and Tetrahydrocurcumin on dextran sulfate sodium-induced colitis and inflammatory signaling in mice. J Cancer Prev. 2018;23(1):18.","journal-title":"J Cancer Prev"},{"issue":"3","key":"1068_CR180","doi-asserted-by":"publisher","first-page":"286","DOI":"10.4103\/0253-7613.132160","volume":"46","author":"D Dodda","year":"2014","unstructured":"Dodda D, et al. Targeting oxidative stress attenuates trinitrobenzene Sulphonic acid induced inflammatory bowel disease like symptoms in rats: role of Quercetin. Indian J Pharmacol. 2014;46(3):286.","journal-title":"Indian J Pharmacol"},{"issue":"1","key":"1068_CR181","doi-asserted-by":"publisher","first-page":"43","DOI":"10.4196\/kjpp.2015.19.1.43","volume":"19","author":"M Joo","year":"2015","unstructured":"Joo M, et al. Anti-inflammatory effects of flavonoids on TNBS-induced colitis of rats. Korean J Physiol Pharmacology: Official J Korean Physiological Soc Korean Soc Pharmacol. 2015;19(1):43.","journal-title":"Korean J Physiol Pharmacology: Official J Korean Physiological Soc Korean Soc Pharmacol"},{"issue":"5","key":"1068_CR182","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1159\/000489447","volume":"46","author":"E-B Byun","year":"2018","unstructured":"Byun E-B, et al. Epigallocatechin-3-gallate regulates anti-inflammatory action through 67-kDa laminin receptor-mediated Tollip signaling induction in lipopolysaccharide-stimulated human intestinal epithelial cells. Cell Physiol Biochem. 2018;46(5):2072\u201381.","journal-title":"Cell Physiol Biochem"},{"key":"1068_CR183","doi-asserted-by":"crossref","unstructured":"Bitzer ZT, et al. (-)\u2010Epigallocatechin\u20103\u2010gallate decreases colonic inflammation and permeability in a mouse model of colitis, but reduces macronutrient digestion and exacerbates weight loss. Volume 60. Molecular nutrition & food research; 2016. pp. 2267\u201374. 10.","DOI":"10.1002\/mnfr.201501042"},{"issue":"2","key":"1068_CR184","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.crohns.2011.08.012","volume":"6","author":"M Br\u00fcckner","year":"2012","unstructured":"Br\u00fcckner M, et al. Green tea polyphenol epigallocatechin-3-gallate shows therapeutic antioxidative effects in a murine model of colitis. J Crohn\u2019s Colitis. 2012;6(2):226\u201335.","journal-title":"J Crohn\u2019s Colitis"},{"issue":"4","key":"1068_CR185","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/j.ajpath.2015.12.004","volume":"186","author":"B San Yeoh","year":"2016","unstructured":"San Yeoh B, et al. Epigallocatechin-3-gallate Inhibition of myeloperoxidase and its counter-regulation by dietary iron and Lipocalin 2 in murine model of gut inflammation. Am J Pathol. 2016;186(4):912\u201326.","journal-title":"Am J Pathol"},{"issue":"4","key":"1068_CR186","first-page":"865","volume":"31","author":"AG Geagea","year":"2017","unstructured":"Geagea AG, et al. Tea catechins induce crosstalk between signaling pathways and stabilize mast cells in ulcerative colitis. J Biol Regulators Homeost Agents. 2017;31(4):865\u201377.","journal-title":"J Biol Regulators Homeost Agents"},{"issue":"6","key":"1068_CR187","first-page":"100","volume":"1","author":"A El-Medany","year":"2011","unstructured":"El-Medany A, et al. Comparative study between effect of angiotensin converting enzyme inhibitors and angiotensin. Res J Pharm Pharmacol. 2011;1(6):100\u20138.","journal-title":"Res J Pharm Pharmacol"},{"issue":"5","key":"1068_CR188","doi-asserted-by":"publisher","first-page":"e97193","DOI":"10.1371\/journal.pone.0097193","volume":"9","author":"HH Arab","year":"2014","unstructured":"Arab HH, et al. Telmisartan attenuates colon inflammation, oxidative perturbations and apoptosis in a rat model of experimental inflammatory bowel disease. PLoS ONE. 2014;9(5):e97193.","journal-title":"PLoS ONE"},{"issue":"2","key":"1068_CR189","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.cyto.2015.03.017","volume":"74","author":"S Arumugam","year":"2015","unstructured":"Arumugam S, et al. Telmisartan treatment targets inflammatory cytokines to suppress the pathogenesis of acute colitis induced by dextran sulphate sodium. Cytokine. 2015;74(2):305\u201312.","journal-title":"Cytokine"},{"key":"1068_CR190","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.pharep.2014.12.011","volume":"67","author":"GC Guerra","year":"2015","unstructured":"Guerra GC, et al. Telmisartan decreases inflammation by modulating TNF-\u03b1, IL-10, and RANK\/RANKL in a rat model of ulcerative colitis. Pharmacol Rep. 2015;67:520\u20136.","journal-title":"Pharmacol Rep"},{"issue":"1","key":"1068_CR191","doi-asserted-by":"publisher","first-page":"17","DOI":"10.4103\/0253-7613.150311","volume":"47","author":"RA Maheshwari","year":"2015","unstructured":"Maheshwari RA, et al. Protective effect of Simvastatin and Rosuvastatin on trinitrobenzene sulfonic acid-induced colitis in rats. Indian J Pharmacol. 2015;47(1):17.","journal-title":"Indian J Pharmacol"},{"issue":"4","key":"1068_CR192","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1111\/imm.12662","volume":"149","author":"A Lei","year":"2016","unstructured":"Lei A, et al. Atorvastatin promotes the expansion of myeloid-derived suppressor cells and attenuates murine colitis. Immunology. 2016;149(4):432\u201346.","journal-title":"Immunology"},{"issue":"25","key":"1068_CR193","doi-asserted-by":"publisher","first-page":"4559","DOI":"10.3748\/wjg.v23.i25.4559","volume":"23","author":"SK Shin","year":"2017","unstructured":"Shin SK, et al. Anti-inflammatory and anti-apoptotic effects of Rosuvastatin by regulation of oxidative stress in a dextran sulfate sodium-induced colitis model. World J Gastroenterol. 2017;23(25):4559.","journal-title":"World J Gastroenterol"},{"key":"1068_CR194","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1007\/s10620-008-0438-0","volume":"54","author":"HR Ancha","year":"2009","unstructured":"Ancha HR, et al. Effects of N-acetylcysteine plus Mesalamine on prostaglandin synthesis and nitric oxide generation in TNBS-induced colitis in rats. Dig Dis Sci. 2009;54:758\u201366.","journal-title":"Dig Dis Sci"},{"issue":"6","key":"1068_CR195","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1111\/jam.12461","volume":"116","author":"C Hou","year":"2014","unstructured":"Hou C, et al. Superoxide dismutase Recombinant Lactobacillus fermentum ameliorates intestinal oxidative stress through inhibiting NF-\u03ba B activation in a trinitrobenzene Sulphonic acid\u2010induced colitis mouse model. J Appl Microbiol. 2014;116(6):1621\u201331.","journal-title":"J Appl Microbiol"},{"issue":"1","key":"1068_CR196","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1124\/jpet.108.144451","volume":"328","author":"T Ishihara","year":"2009","unstructured":"Ishihara T, et al. Therapeutic effect of lecithinized superoxide dismutase against colitis. J Pharmacol Exp Ther. 2009;328(1):152\u201364.","journal-title":"J Pharmacol Exp Ther"},{"issue":"36","key":"1068_CR197","doi-asserted-by":"publisher","first-page":"5065","DOI":"10.3748\/wjg.v18.i36.5065","volume":"18","author":"G Merra","year":"2012","unstructured":"Merra G, et al. Propionyl-L-carnitine hydrochloride for treatment of mild to moderate colonic inflammatory bowel diseases. World J Gastroenterology: WJG. 2012;18(36):5065.","journal-title":"World J Gastroenterology: WJG"},{"issue":"3","key":"1068_CR198","doi-asserted-by":"publisher","first-page":"e55","DOI":"10.1038\/ctg.2014.4","volume":"5","author":"MG Scioli","year":"2014","unstructured":"Scioli MG, et al. Propionyl-L-carnitine is efficacious in ulcerative colitis through its action on the immune function and microvasculature. Clin Translational Gastroenterol. 2014;5(3):e55.","journal-title":"Clin Translational Gastroenterol"},{"issue":"9853","key":"1068_CR199","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1016\/S0140-6736(12)60026-9","volume":"380","author":"DC Baumgart","year":"2012","unstructured":"Baumgart DC, Sandborn WJ. Crohn\u2019s disease. Lancet. 2012;380(9853):1590\u2013605.","journal-title":"Lancet"},{"key":"1068_CR200","first-page":"23","volume":"1","author":"S Guandalini","year":"2014","unstructured":"Guandalini S. Are probiotics or prebiotics useful in pediatric irritable bowel syndrome or inflammatory bowel disease? Front Med (Lausanne). 2014;1:23.","journal-title":"Front Med (Lausanne)"},{"issue":"10","key":"1068_CR201","doi-asserted-by":"publisher","first-page":"999","DOI":"10.3390\/ph7100999","volume":"7","author":"MH Floch","year":"2014","unstructured":"Floch MH. Recommendations for probiotic use in humans\u2014a 2014 update. Pharmaceuticals. 2014;7(10):999\u20131007.","journal-title":"Pharmaceuticals"},{"issue":"6","key":"1068_CR202","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1080\/19490976.2017.1345414","volume":"8","author":"M Rondanelli","year":"2017","unstructured":"Rondanelli M, et al. Using probiotics in clinical practice: where are we now? A review of existing meta-analyses. Gut Microbes. 2017;8(6):521\u201343.","journal-title":"Gut Microbes"},{"issue":"11","key":"1068_CR203","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1136\/gut.2003.037747","volume":"53","author":"W Kruis","year":"2004","unstructured":"Kruis W, et al. Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine. Gut. 2004;53(11):1617\u201323.","journal-title":"Gut"},{"issue":"9","key":"1068_CR204","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1055\/s-2008-1027463","volume":"46","author":"J Henker","year":"2008","unstructured":"Henker J, et al. Probiotic Escherichia coli Nissle 1917 (EcN) for successful remission maintenance of ulcerative colitis in children and adolescents: an open-label pilot study. Z Gastroenterol. 2008;46(9):874\u20135.","journal-title":"Z Gastroenterol"},{"issue":"7","key":"1068_CR205","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1111\/j.1572-0241.2005.41794.x","volume":"100","author":"R Bibiloni","year":"2005","unstructured":"Bibiloni R, et al. VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis. Am J Gastroenterol. 2005;100(7):1539\u201346.","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"1068_CR206","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1097\/01.MIB.0000437495.30052.be","volume":"20","author":"J Shen","year":"2014","unstructured":"Shen J, Zuo ZX, Mao AP. Effect of probiotics on inducing remission and maintaining therapy in ulcerative colitis, crohn\u2019s disease, and pouchitis: meta-analysis of randomized controlled trials. Inflamm Bowel Dis. 2014;20(1):21\u201335.","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"1068_CR207","first-page":"1","volume":"5","author":"ACP Hotel","year":"2001","unstructured":"Hotel ACP, Cordoba A. Health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. Prevention. 2001;5(1):1\u201310.","journal-title":"Prevention"},{"issue":"5484","key":"1068_CR208","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1126\/science.289.5484.1560","volume":"289","author":"AS Neish","year":"2000","unstructured":"Neish AS, et al. Prokaryotic regulation of epithelial responses by Inhibition of I\u03baB-\u03b1 ubiquitination. Science. 2000;289(5484):1560\u20133.","journal-title":"Science"},{"issue":"5","key":"1068_CR209","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1053\/j.gastro.2004.09.001","volume":"127","author":"EO Petrof","year":"2004","unstructured":"Petrof EO, et al. Probiotics inhibit nuclear factor-kappaB and induce heat shock proteins in colonic epithelial cells through proteasome Inhibition. Gastroenterology. 2004;127(5):1474\u201387.","journal-title":"Gastroenterology"},{"issue":"1","key":"1068_CR210","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/j.1574-6968.2011.02470.x","volume":"328","author":"CH Kim","year":"2012","unstructured":"Kim CH, et al. Probiotic genomic DNA reduces the production of pro-inflammatory cytokine tumor necrosis factor-alpha. FEMS Microbiol Lett. 2012;328(1):13\u20139.","journal-title":"FEMS Microbiol Lett"},{"issue":"1","key":"1068_CR211","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/ni1018","volume":"5","author":"D Kelly","year":"2004","unstructured":"Kelly D, et al. Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-\u03b3 and rela. Nat Immunol. 2004;5(1):104\u201312.","journal-title":"Nat Immunol"},{"issue":"11","key":"1068_CR212","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1002\/ibd.20999","volume":"15","author":"C Reiff","year":"2009","unstructured":"Reiff C, et al. Balancing inflammatory, lipid, and xenobiotic signaling pathways by VSL# 3, a biotherapeutic agent, in the treatment of inflammatory bowel disease. Inflamm Bowel Dis. 2009;15(11):1721\u201336.","journal-title":"Inflamm Bowel Dis"}],"updated-by":[{"DOI":"10.1186\/s12986-026-01191-4","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000}}],"container-title":["Nutrition &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12986-025-01068-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12986-025-01068-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12986-025-01068-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T07:02:19Z","timestamp":1787727739000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12986-025-01068-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,21]]},"references-count":212,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1068"],"URL":"https:\/\/doi.org\/10.1186\/s12986-025-01068-y","relation":{},"ISSN":["1743-7075"],"issn-type":[{"value":"1743-7075","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,21]]},"assertion":[{"value":"26 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12986-026-01191-4","URL":"https:\/\/doi.org\/10.1186\/s12986-026-01191-4","order":9,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"157"}}